Work

International epidemiology of human pre-existing adenovirus (Ad) type-5, type-6, type-26 and type-36 neutralizing antibodies: Correlates of high Ad5 titers and implications for potential HIV vaccine trials

Year: 2009

Type: article

Study design: Observational Study

Source: Vaccine

DOI: 10.1016/j.vaccine.2009.10.145

Authors: T. Christopher Mast, Lisa Kierstead, Swati B. Gupta, Alexander A. Nikas, Esper G. Kallas, Vladimir Novitsky, Bernard Mbewe, Punee Pitisuttithum, Mauro Schechter, Eftyhia Vardas, Nathan D. Wolfe, Miguel Aste-Amezaga, Danilo R. Casimiro, Paul Coplan, Walter L. Straus, John W. Shiver

Institutions: Merck & Co., Inc., Rahway, NJ, USA (United States), Universidade Federal de São Paulo, Harvard University, Mahidol University, Mahidol Oxford Tropical Medicine Research Unit, Universidade Federal do Rio de Janeiro, University of the Witwatersrand, Perinatal HIV Research Unit, Johns Hopkins University

Language: English

Topic: Virus-based gene therapy research

Subfield: Genetics

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W1968487372

FWCI: 9.47

Cites: 37

Cited by: 276

Related to: 10